Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386,127,219
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
64,001,413
-
Shares change
-
-305,105
-
Total reported value, excl. options
-
$222,706,158
-
Value change
-
-$9,721,596
-
Number of buys
-
45
-
Number of sells
-
-71
-
Price
-
$3.48
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q4 2019
138 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q4 2019.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64,001,413 shares
of 386,127,219 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (6,477,843 shares), Russell Investments Group, Ltd. (5,859,832 shares), Neuberger Berman Group LLC (5,669,341 shares), BlackRock Inc. (5,290,321 shares), VANGUARD GROUP INC (4,409,776 shares), Levin Easterly Partners LLC (4,383,647 shares), Indaba Capital Management, L.P. (3,322,988 shares), Partner Fund Management, L.P. (3,234,984 shares), RENAISSANCE TECHNOLOGIES LLC (2,788,100 shares), and ACADIAN ASSET MANAGEMENT LLC (1,687,681 shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.